The Readout Loud

Latest Episodes:

Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH Feb 14, 2019

Show notes

When will AI replace your radiologist? What can pharma learn from ketamine? And is liver disease more complicated than anyone thought?

Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from? Feb 07, 2019

Show notes

Are we underestimating biology? Will Hot 97 decide the presidency? And who owns the scientific means of production?

Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns Jan 31, 2019

Show notes

Is the drug industry wrong about Alzheimer's disease? Can cryptocurrency fund actual science? And should you feel sorry for Big Pharma?

Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics Jan 24, 2019

Show notes

Is genome editing harder than anyone thought? Will no one weep for Celgene? And is it time to sequence your dog?

Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics Jan 17, 2019

Show notes

Is the FDA going broke? Can video games be drugs? And when did "Flashdance" come out?

Episode 43: A people's history of J.P. Morgan Jan 10, 2019

Show notes

Do drug developers tip well? Is biotech safe for 6-year-olds? And what's a Cable Car Cosmo?

Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring Jan 03, 2019

Show notes

Are megamergers bad for business? Is it time for biotech's biggest gathering to find a new home? And can a "need" be anything but "unmet"?

Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta Dec 20, 2018

Show notes

What will become of biotech in 2019? What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?

Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests Dec 13, 2018

Show notes

Is Gilead Sciences entering a bold new era? What even happened in 2018? And how useful is a genetic credit score?

Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history Dec 06, 2018

Show notes

Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019?